MM

Martha Margarat Devarapalli

Active Director Director DIN 09722666
DIN 09722666 First appointment Aug 2022 Primary industry Research & Development
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Martha Margarat Devarapalli

Data last updated:

Martha Margarat Devarapalli is a Director at Eonian Biotech Private Limited (since 2022). The company operates in Research & Development.

DIN 09722666
Primary Designation Director
Industry Research & Development
First Appointment 31 Aug 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Eonian Biotech Private Limited U73100TG2022PTC166217
Director31 Aug 20222022Active

Board colleagues of Martha Margarat Devarapalli

Directorship timeline

Open interactive timeline →
Eonian Biotech Private Limited
Premium access

Shareholding and investment profile for Martha Margarat Devarapalli

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Martha Margarat Devarapalli

Martha Margarat Devarapalli currently holds 1 directorship: Eonian Biotech Private Limited (Director, since 31 Aug 2022).

Martha Margarat Devarapalli was first appointed on 31 Aug 2022 as Director at Eonian Biotech Private Limited.

The current boards of Martha Margarat Devarapalli's companies include Gunturu Chandrakala (Eonian Biotech Private Limited), Kezia Devarapalli (Eonian Biotech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available